These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8813126

  • 1. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H, Villegas C, Huang A, Wright JA.
    Cancer Res; 1996 Oct 01; 56(19):4366-9. PubMed ID: 8813126
    [Abstract] [Full Text] [Related]

  • 2. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).
    Burton TR, Kashour T, Wright JA, Amara FM.
    Int J Oncol; 2003 Jan 01; 22(1):21-31. PubMed ID: 12469181
    [Abstract] [Full Text] [Related]

  • 3. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA, Wright JA.
    J Cell Physiol; 1994 Jan 01; 158(1):187-97. PubMed ID: 7505277
    [Abstract] [Full Text] [Related]

  • 4. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
    Amara FM, Hurta RA, Huang A, Wright JA.
    Cancer Res; 1995 Oct 15; 55(20):4503-6. PubMed ID: 7553616
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
    Cao MY, Lee Y, Feng NP, Xiong K, Jin H, Wang M, Vassilakos A, Viau S, Wright JA, Young AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4553-61. PubMed ID: 14555530
    [Abstract] [Full Text] [Related]

  • 6. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
    Fan H, Villegas C, Huang A, Wright JA.
    Cancer Res; 1998 Apr 15; 58(8):1650-3. PubMed ID: 9563477
    [Abstract] [Full Text] [Related]

  • 7. GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors.
    Lee Y, Vassilakos A, Feng N, Jin H, Wang M, Xiong K, Wright J, Young A.
    Int J Oncol; 2006 Feb 15; 28(2):469-78. PubMed ID: 16391803
    [Abstract] [Full Text] [Related]

  • 8. A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
    Amara FM, Smith GM, Kuschak TI, Takeuchi TL, Wright JA.
    Biochem Biophys Res Commun; 1996 Nov 12; 228(2):347-51. PubMed ID: 8920917
    [Abstract] [Full Text] [Related]

  • 9. GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.
    Lee Y, Vassilakos A, Feng N, Lam V, Xie H, Wang M, Jin H, Xiong K, Liu C, Wright J, Young A.
    Cancer Res; 2003 Jun 01; 63(11):2802-11. PubMed ID: 12782585
    [Abstract] [Full Text] [Related]

  • 10. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA, Wright JA.
    J Cell Biochem; 1995 Mar 01; 57(3):543-56. PubMed ID: 7768988
    [Abstract] [Full Text] [Related]

  • 11. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA.
    Wang E, Ma WJ, Aghajanian C, Spriggs DR.
    Cancer Res; 1997 Dec 01; 57(23):5426-33. PubMed ID: 9393771
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA, Greenberg AH, Wright JA.
    J Cell Physiol; 1992 Sep 01; 152(3):529-35. PubMed ID: 1506411
    [Abstract] [Full Text] [Related]

  • 13. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS, Li L, Garson K, Vanderhyden BC.
    Zhonghua Zhong Liu Za Zhi; 2006 Dec 01; 28(12):881-5. PubMed ID: 17533735
    [Abstract] [Full Text] [Related]

  • 14. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
    Taylor WR, Egan SE, Mowat M, Greenberg AH, Wright JA.
    Oncogene; 1992 Jul 01; 7(7):1383-90. PubMed ID: 1620551
    [Abstract] [Full Text] [Related]

  • 15. [Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice].
    Wang BH, Qian W, Gao YJ, Wang HF, Hou XH.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 24; 86(4):266-71. PubMed ID: 16677508
    [Abstract] [Full Text] [Related]

  • 16. The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.
    Fan H, Huang A, Villegas C, Wright JA.
    Proc Natl Acad Sci U S A; 1997 Nov 25; 94(24):13181-6. PubMed ID: 9371820
    [Abstract] [Full Text] [Related]

  • 17. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.
    Kashani-Sabet M, Funato T, Florenes VA, Fodstad O, Scanlon KJ.
    Cancer Res; 1994 Feb 15; 54(4):900-2. PubMed ID: 8313379
    [Abstract] [Full Text] [Related]

  • 18. Norepinephrine specifically stimulates ribonucleotide reductase subunit R2 gene expression in proliferating brown adipocytes: mediation via a cAMP/PKA pathway involving Src and Erk1/2 kinases.
    Fredriksson JM, Nedergaard J.
    Exp Cell Res; 2002 Apr 01; 274(2):207-15. PubMed ID: 11900481
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
    Kröger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J, Hauser H.
    Cancer Res; 2007 Apr 01; 67(7):2972-81. PubMed ID: 17409403
    [Abstract] [Full Text] [Related]

  • 20. Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and posttranscriptional mechanisms.
    Wang XY, McCubrey JA.
    Cell Growth Differ; 1996 Apr 01; 7(4):487-500. PubMed ID: 9052990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.